BiChemoCLAM: a weakly supervised multimodal framework for chemotherapy response prediction
Briefings in Bioinformatics · 07.01.2026 · 27 (1)
DOI: 10.1093/bib/bbaf728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 26.01.2026. Verfasst von Jinglong Gui und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Software, College of Intelligence and Computing, Tianjin University, Ya Guan Road No. 135, Haihe Education Park, Jinnan District, …. Hauptthemen laut MEDLINE: Deep Learning, Urinary Bladder Neoplasms, Antineoplastic Agents, Supervised Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, Tianjin Health Industry High-level Talent Selection and Training Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy is an important treatment for cancer patients, but it comes with risks. Therefore, effective chemotherapy response prediction is crucial. While whole slide image provides high-resolution insights into tumour environments, existing weakly supervised learning frameworks struggle to effectively integrate molecular data, such as gene expression, limiting their predictive power in complex chemotherapy response and small-sample scenarios. We present a bimodal chemotherapy response multi-instance learning framework, BiChemoCLAM, a novel multimodal deep learning framework that combines attention-driven multiple instance learning with multimodal compact bilinear pooling for interpretable and data-efficient chemotherapy response prediction. It achieves an Area Under Curve (AUC) of 80.91%, 71.68%, and 75.80% on ovarian serous cystadenocarcinoma, colorectal adenocarcinoma, and bladder urothelial carcinoma cancer datasets, respectively. The experimental results show that BiChemoCLAM is an effective model for predicting response to chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computer Software, College of Intelligence and Computing, Tianjin University, Ya Guan Road No. 135, Haihe Education Park, Jinnan District, Tianjin, 300354, China.
- CSIRO Data61, PO Box 76, Epping, NSW 1710, Australia.
- Chest Hospital, Tianjin University, No. 261, Taierzhuang South Road, Jinnan District, Tianjin, 300222, China.
- Centre for Artificial Intelligence driven Drug Discovery, Faculty of Applied Science, Macao Polytechnic University, Rua de Luís Gonzaga Gomes, Macao SAR, China.
- School of Information, Xiamen University, Xiang'an District, Xiamen City, Fujian Province, 361005, China.
- Tianjin Medical University Cancer Institute and Hospital, The First Department of Breast Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, West Huan-Hu Rd, Ti Yuan Bei, Hexi District…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin
- Tianjin Health Industry High-level Talent Selection and Training Project
Zitieren
APA
Gui, J., Sun, C., Zhou, J., Xie, C., Wei, L., Zhao, J., Liu, X., & Su, R. (2026). BiChemoCLAM: a weakly supervised multimodal framework for chemotherapy response prediction. Briefings in Bioinformatics, 27(1). https://doi.org/10.1093/bib/bbaf728
Vancouver
Gui J, Sun C, Zhou J, Xie C, Wei L, Zhao J, et al. BiChemoCLAM: a weakly supervised multimodal framework for chemotherapy response prediction. Briefings in Bioinformatics. 2026;27(1). doi:10.1093/bib/bbaf728
BibTeX
@article{Gui2026,
author = {Gui, Jinglong and Sun, Changming and Zhou, Jia and Xie, Cun and Wei, Leyi and Zhao, Jia and Liu, Xiaofeng and Su, Ran},
title = {BiChemoCLAM: a weakly supervised multimodal framework for chemotherapy response prediction},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {1},
doi = {10.1093/bib/bbaf728}
}
EUVIMED